02138 Union Medical Healthcare

EQS-Announcement: Union Medical Healthcare Makes First Foray into The Capital of China


EQS-Announcement
Union Medical Healthcare Makes First Foray into The Capital of China


26/02/2019 / 22:48 UTC+8
The issuer is solely responsible for the content of this announcement.

[FOR IMMEDIATE RELEASE]
/
Union Medical Healthcare Makes First Foray into The Capital of China


(26 February 2019, Hong Kong) Union Medical Healthcare Limited ("Union Medical Healthcare" or the "Company", which together with its subsidiaries, is referred to as the "Group", SEHK stock code: 2138), a leading integrated medical group in Hong Kong, is pleased to announce that it has entered into an agreement to acquire a company holding a medical institution practicing license and is principally engaged in the provision of medical aesthetic services in China. Located in Chaoyang District in Beijing, the premises occupies approximately 900 square meters.

Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of Union Medical Healthcare, said, "The acquisition marks the Group's first foray into the capital of China, Beijing and strides our business expansion in the Greater China. With our current footprint across all first-tier cities in China, riding on the Chinese goverment's policy of fostering coordinated development of the Guangdong-Hong Kong-Macao Greater Bay Area, the increase in our brand awareness shall drive medical tourism. The Group will increase its share of Greater China's market for medical and aesthetic services, aspiring to become a leading integrated medical group in the region."

-End-

About Union Medical Healthcare Limited
Leveraging its core businesses of preventive and precision medicine, Union Medical Healthcare is committed to developing medical artificial intelligence by integrating its multi-discipline medical services. The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective medical services with professionalism.

The Group principally engages in the provision of one-stop medical and health care services in Greater China at its 55 clinics and service centres with an aggregate service floor area of more than 275,000 square feet. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, primary care clinics jointly established with Tencent Doctorwork, chiropractic services centre SPINE Central, health management centre re:HEALTH and comprehensive dental centre UMH DENTAL CARE. In addition, the Group has put into operation such businesses as a diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED and a specialty clinic SPECIALISTS CENTRAL.

For further information, please contact:
iPR Ogilvy & Mather

Callis Lau / Molisa Lau / Maggie Chui / Francesca Yeung / Chloe Cheung / Vivian Lam
Tel: (852) 2136 6952 / 2136 6953 / 2136 8059 / 3920 7639 / 3920 7650 /3920 7647
Email:

26/02/2019 Dissemination of an Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

Media archive at

fncls.ssp?fn=show_t_gif&application_id=781339&application_name=news&site_id=research_pool
EN
26/02/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Union Medical Healthcare

EC Healthcare: 1 director

A director at EC Healthcare bought 1,000,000 shares at 7.247HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

 PRESS RELEASE

医思医疗建议采纳共同持股计划,鼓励优质人才留任ï...

EQS 公告 医思医疗建议采纳共同持股计划,鼓励优质人才留任,为股东创造价值 2020-02-25 / 09:43 UTC+8 【请实时发布】     医思医疗建议采纳共同持股计划 鼓励优质人才留任 为股东创造价值   (2020å¹´2月25日,香港)香港具领导地位的综合医疗集团 ── 香港医思医疗集团有限公司(「医思医疗」或本「公司」,连同附属公司,总称本「集团」;香港联交所股份编号:2138)公布,向包括选定董事及雇员或服务供货商等合资格参与者提供共同投èµ...

 PRESS RELEASE

EQS-Announcement: Union Medical Healthcare Limited proposes adoption o...

EQS-Announcement Union Medical Healthcare Limited proposes adoption of Co-ownership plan to retain talents and create value for shareholders 25/02/2020 / 09:43 UTC+8 The issuer is solely responsible for the content of this announcement. 【For Immediate Release】     Union Medical Healthcare Limited proposes adoption of Co-ownership plan to retain talents and create value for shareholders   (25 February 2020, Hong Kong) - Union Medical Healthcare Limited ("Union Medical Healthcare" or the "Company", which together with its subsidiaries, is referred to as the "Group"; SEHK stock ...

 PRESS RELEASE

醫思醫療建議採納共同持股計劃 ,鼓勵優質人才留任...

EQS 公告 醫思醫療建議採納共同持股計劃 ,鼓勵優質人才留任,為股東創造價值 2020-02-25 / 09:43 UTC+8 【請即時發佈】     醫思醫療建議採納共同持股計劃 鼓勵優質人才留任 為股東創造價值   (2020å¹´2月25日,香港)香港具領導地位的綜合醫療集團 ── 香港醫思醫療集團有限公司(「醫思醫療」或本「公司」,連同附屬公司,總稱本「集團」;香港聯交所股份編號:2138)公佈,向包括選定董事及僱員或服務供應商等合資格參與者提供共同投è...

 PRESS RELEASE

EQS-Announcement: Union Medical Healthcare Announces FY2019/20 Interim...

EQS-Announcement Union Medical Healthcare Announces FY2019/20 Interim Results, Union Medical Healthcare Announces FY2019/20 Interim Results. Business growth driven by medical services with increase in net profit to HK$211 million 26/11/2019 / 20:54 UTC+8 The issuer is solely responsible for the content of this announcement. [FOR IMMEDIATE RELEASE] / Union Medical Healthcare Announces FY2019/20 Interim Results Business growth driven by medical services with increase in net profit to HK$211 million Results Highlights Revenue increased by 28.1% to HK$1,118.5 million Net profit mar...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch